Skip to main content
ATAI
NASDAQ Life Sciences

Atai Beckley N.V. Completes Redomiciliation to Delaware, Becomes AtaiBeckley Inc.

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.16
Mkt Cap
$1.486B
52W Low
$1.15
52W High
$6.75
52W Position info
262% above low
Off High info
38% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ATAI has more than doubled off its 52-week low of $1.15.

Summary

Atai Beckley N.V. has completed its redomiciliation from the Netherlands to Delaware, becoming AtaiBeckley Inc., and consequently deregistered unsold securities from a previous S-3 shelf registration.


Key Events · Corporate Governance and Compliance · ATAI

  • Corporate Redomiciliation Completed

    Atai Beckley N.V. merged into a Luxembourg entity, which then converted into a Delaware corporation named AtaiBeckley Inc., completing its redomiciliation.

  • Deregistration of Unsold Securities

    As a result of the redomiciliation, the company terminated all offerings under its previous S-3 registration statement and deregistered all unsold securities.


Analysis · ATAI · Life Sciences

This filing confirms the completion of a significant corporate restructuring, moving the company's legal domicile from the Netherlands to Delaware. This change can have implications for corporate governance, legal jurisdiction, and potentially future capital market activities. The deregistration of unsold securities is a procedural step following this redomiciliation, clearing the previous shelf registration. Investors should note the change in legal entity and domicile.

At the time of this filing, ATAI was trading at $4.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $1.15 to $6.75. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATAI - Latest Insights

ATAI
Jul 17, 2026, 5:17 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $7.17
Real-time Price: $7.14 info
Change: -$0.030 (-0.42%) info
Market Cap: $2.656B info
ATAI
Jul 16, 2026, 7:28 AM EDT
Filing Type: DEFA14A
Importance Score:
10
Price at Filing: $7.20
Real-time Price: $7.14 info
Change: -$0.060 (-0.83%) info
Market Cap: $2.656B info
ATAI
Jul 16, 2026, 7:27 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $7.20
Real-time Price: $7.14 info
Change: -$0.060 (-0.83%) info
Market Cap: $2.656B info
ATAI
Jul 16, 2026, 7:07 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $7.21
Real-time Price: $7.14 info
Change: -$0.070 (-0.97%) info
Market Cap: $2.656B info
ATAI
Jul 16, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $8.82
Real-time Price: $7.14 info
Change: -$1.68 (-19%) info
Market Cap: $2.656B info